AMILI
AMILI is a precision gut microbiome company based in Singapore serving the region.
40 employees · est. 2019 · Singapore, Singapore
Xbiome
China's leading AI-driven microbiome drug development company
51 employees · est. 2017 · Cambridge, United States
Xbiome is the older company (2019 vs 2017); Xbiome is the larger of the two.
Side-by-Side Comparison
| Metric | AMILI | Xbiome |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2017 older |
| Headquarters | ||
| Headquarters | Singapore, Singapore | Cambridge, United States |
| Employees | ||
| Employees | 40 | 51 larger |
| Industry | ||
| Industry | Health Care, Health and Wellness, Sports | AI, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series B |
| Total Funding | ||
| Total Funding | $10.50M | $210.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Not tracked yet | Technology Platform Development, Pharmaceutical Research, Drug Pipeline Management, Collaboration with Scientific and Medical Communities |
| Target Customers | ||
| Target Customers | Not tracked yet | Biotech and Pharma Companies, Healthcare Organizations, Research Institutions, Scientific Community |
| Taxonomy | ||
| Taxonomy | Precision Gut Microbiome, Diagnostics Tests, Predictive Algorithms, Microbiome-Modifying Interventions, Consumer Health, Personalised Diet, Supplementation, Precision Health, Microbiome Database, Faecal Microbiota Transplants, Stool Bank, Research And Development, Innovation, Probiotics | AI-driven Drug Development, Microbiome Therapeutics, Gut Health Management, Personalized Medicine, Bioinformatics, Microbial Technology, Intestinal Micro-ecology, Pharmaceutical Innovation, Dysbiosis Solutions, Microbiota Analysis, Artificial Intelligence In Healthcare, Precision Health, Microbial Ecosystem Analysis, Human Microbiome |
| Website | ||
| Website | amili.asia | xbiome.com |
About AMILI
AMILI is a precision gut microbiome company based in Singapore, serving the region. Through AMILI's proprietary analytics engine, PRIME, they develop diagnostics tests, predictive algorithms, and microbiome-modifying interventions. Their consumer health arm, BIO & ME, utilizes insights from AMILI's...
About Xbiome
Xbiome, established in 2017, is touted as China's leading AI-driven microbiome drug development company. As a pioneer in AI-based solutions, it aims to transform the biotechnology and pharmaceutical sectors, focusing on gut microbiome using sophisticated AI techniques. This approach to health levera...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at AMILI and Xbiome — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at AMILI and Xbiome — by email.
Frequently Asked Questions
Compare AMILI with someone else
Start typing a company name or domain.